To include your compound in the COVID-19 Resource Center, submit it here.

PTC rebounds following Translarna adcomm

PTC Therapeutics Inc. (NASDAQ:PTCT) gained $2.55 (15%) to $20.01 Friday after FDA's

Read the full 122 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE